These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16465600)

  • 21. A Phase II study of docetaxel and carboplatin in the treatment of non-small cell lung cancer.
    Zarogoulidis K; Kontakiotis T; Hatziapostolou P; Fachantidou E; Delis D; Goutsikas J; Constantinidis TC; Athanasiadis A; Patakas D
    Lung Cancer; 2001 Jun; 32(3):281-7. PubMed ID: 11390009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I/II trial of docetaxel and carboplatin as a first-line therapy in patients with stage IV non-small-cell lung cancer.
    Kataoka K; Suzuki R; Taniguchi H; Noda Y; Shindoh J; Matsumoto S; Watanabe Y; Honda K; Suzuki K; Baba K; Imaizumi K; Kume H; Hasegawa Y; Takagi K
    Lung; 2006; 184(3):133-9. PubMed ID: 16902837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma.
    Socinski MA; Sandler AB; Israel VK; Gillenwater HH; Miller LL; Locker PK; Antonellini A; Elfring GL; Natale RB
    Cancer; 2002 Oct; 95(7):1520-7. PubMed ID: 12237921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).
    Johnson DH; Paul DM; Hande KR; DeVore R
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):42-6. PubMed ID: 9007120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study.
    Giannakakis T; Ziras N; Kakolyris S; Mavroudis D; Androulakis N; Agelaki S; Parashos M; Sarra E; Dimou T; Hatzidaki D; Vlachonikolis J; Georgoulias V
    Eur J Cancer; 2000 Apr; 36(6):742-7. PubMed ID: 10762746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.
    Reck M; Macha HN; Del Barco S; Cornes P; Vaissière N; Morand M; Riggi M; Abratt R
    Lung Cancer; 2009 Jun; 64(3):319-25. PubMed ID: 19095327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination chemotherapy with carboplatin, docetaxel, and gemcitabine in advanced non-small-cell lung cancer: a phase II study.
    Pectasides D; Aspropotamitis A; Halikia A; Visvikis A; Antoniou F; Kalantaridou A; Karvounis N; Batzios S; Athanassiou A
    J Clin Oncol; 1999 Dec; 17(12):3816-21. PubMed ID: 10577854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.
    Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Ozols RF
    J Clin Oncol; 1995 Aug; 13(8):1860-70. PubMed ID: 7543559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Docetaxel and carboplatin as first-line therapy in advanced non-small cell lung carcinoma: a phase II study.
    Jahanzeb M; Sarna G; Hirsch R; Radice P; Koletsky A; Martinez M; Kruglyak E; Wolin E; Camacho E; Kronish L; Motl S
    Anticancer Res; 2004; 24(2C):1239-42. PubMed ID: 15154653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of docetaxel and carboplatin as second-line treatment in NSCLC.
    Wachters FM; van Putten JW; Boezen HM; Groen HJ
    Lung Cancer; 2004 Aug; 45(2):255-62. PubMed ID: 15246198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer.
    Chiappori A; Simon G; Williams C; Haura E; Rocha-Lima C; Wagner H; Bepler G; Antonia S
    Oncology; 2005; 68(4-6):382-90. PubMed ID: 16020967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized phase 3 trial comparing pemetrexed/carboplatin and docetaxel/carboplatin as first-line treatment for advanced, nonsquamous non-small cell lung cancer.
    Rodrigues-Pereira J; Kim JH; Magallanes M; Lee DH; Wang J; Ganju V; Martínez-Barrera L; Barraclough H; van Kooten M; Orlando M
    J Thorac Oncol; 2011 Nov; 6(11):1907-14. PubMed ID: 22005471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancer.
    Socinski MA; Sandler AB; Miller LL; Locker PK; Hanover CK; Elfring GL; Israel VK; Pirotta N; Natale RB
    J Clin Oncol; 2001 Feb; 19(4):1078-87. PubMed ID: 11181672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concomitant chemoradiotherapy using pemetrexed and carboplatin for unresectable stage III non-small cell lung cancer (NSCLC): preliminary results of a phase II study.
    Xu Y; Ma S; Ji Y; Sun X; Jiang H; Chen J; Du X; Zheng Y; Qiu G
    Lung Cancer; 2011 Jun; 72(3):327-32. PubMed ID: 21056507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial.
    Johnson DH; Paul DM; Hande KR; Shyr Y; Blanke C; Murphy B; Lewis M; De Vore RF
    J Clin Oncol; 1996 Jul; 14(7):2054-60. PubMed ID: 8683236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer.
    Kelly K; Pan Z; Murphy J; Huffman DH; Bunn PA
    Clin Cancer Res; 1997 Jul; 3(7):1117-23. PubMed ID: 9815791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combination chemotherapy with carboplatin and docetaxel for elderly patients with non-small-cell lung cancer].
    Terashima T; Matsuzaki T; Ogawa R; Naitou A; Morishita T; Ishizaka A
    Nihon Kokyuki Gakkai Zasshi; 2008 Jul; 46(7):516-21. PubMed ID: 18700567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer.
    Takiguchi Y; Iwasawa S; Minato K; Miura Y; Gemma A; Noro R; Yoshimori K; Shingyoji M; Hino M; Ando M; Okamoto H
    Int J Clin Oncol; 2015 Aug; 20(4):659-67. PubMed ID: 25301566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
    Belani CP
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
    Herbst RS; Hammond LA; Carbone DP; Tran HT; Holroyd KJ; Desai A; Williams JI; Bekele BN; Hait H; Allgood V; Solomon S; Schiller JH
    Clin Cancer Res; 2003 Sep; 9(11):4108-15. PubMed ID: 14519633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.